The following trial balance of Reese Corp. at December 31, 2020 has been properly adjusted.

Reese Corp. Trial Balance December 31, 2020
				Dr.	Cr.
			Cash	$875,000
Accounts receivable (net)	2,695,000
Inventory	2,085,000
Property, plant, and equipment (net)	8,269,000
Accounts payable and accrued liabilities		$1,761,000
Income taxes payable		654,000
Deferred income tax liability		85,000
Common stock		2,350,000
Additional paid-in capital		3,680,000
Retained earnings, 1/1/20		3,490,000
Net sales and other revenues		13,560,000
Costs and expenses	11,180,000
Income tax expense	476,000
	$25,580,000	$25,580,000

Other financial data for the year ended December 31, 2020:

• Included in accounts receivable is $1,200,000 due from a customer and payable in quarterly installments of $150,000. The last payment is due December 29, 2022.
• During the year, estimated tax payments of $525,000 were charged to income tax expense. The current and future tax rate on all types of income is 30%.

In Reese's December 31, 2020 balance sheet, the total of current assets is

Group of answer choices

$5,655,000

$5,055,000

$6,180,000

$5,505,000